Poster Sessions 3-3: Immunotherapy

Friday, 16 October 2015: 12:30 - 13:30
Hall D1 Foyer (Floor 3) (Coex Convention Center)
Chairpersons:   Seon Tae Kim (South Korea), Giovanni Passalacqua (Italy), Amir Hamzah Abdul Latiff (Malaysia)
3104
3104: Subcutaneous immunotherapy mouse model for atopic dermatitis | Seo Hyeong Kim (South Korea)
3105
3105: Differences of Change in Der p IgG4 and CD4+CD25+FoxP3+ Treg Cells Between Sublingual and Subcutaneous Immunotherapy with House Dust Mite in Chinese Patients with Allergic Rhinitis | MO Xian (China)
3106
3106: Occupational Allergy to Fungal Spores Among the Farmers of Paddy Fields in West Bengal, India: An Aeromycological and Immunological Approach | Mouli SAHA (India)
3107
3107: Study of Efficacy of Sublingual Immunotherapy (SLIT) in Cases of Severe Persistent Allergic Rhinitis | Subir Jain (India)
3108
3108: The Prevalence of Positive Reaction for Skin Prick Test in Korean Farmers and Its Occupational Risk Factors | Hogil Kim (South Korea)
3109
3109: The Change of Serous Sige and Three Evaluation before and after Sublingual Immunotherapy with Dermatophagoides Farinae for Persistent Allergic Rhinitis | Yongping Liu (China)
3110
3110: Effective Treatment of House Dust Mite (HDM) Allergic Rhinitis with the SQ HDM Slit-Tablet; Results from a Dbpc Phase III Trial | Pascal Demoly (France)
3111
3111: Dose optimizing study of a depigmented polymerized allergen extract of phleum pollen by means of conjunctival provocation test (CPT) | Angelika Sager (Germany)
3112
3112: Allergy Immunotherapy Well Tolerated in Children | Mahnaz Sadeghi-Shabestari (Iran)
3113
3113: Effect on quality of life of the mixed house dust mite/weed pollen extract immunotherapy in polysensitized patients | Lisha Li (China)
3114
3114: Local and systemic reactions of dust mite subcutaneous immunotherapy (SCIT) among children in a tertiary care hospital | Pilar Agnes Gonzalez Andaya (Philippines)
3115
3115: Time course of serum inhibitory activity for facilitated allergen-IgE binding during house dust mite immunotherapy | Mulin Feng (China)
3116
3116: Liposomal encapsulation of house dust mite allergens and dexamethasone modulates allergic response in a murine model of asthma | Yordanis Pérez-Llano (Cuba)
3117
3117: Allergen specific immunotherapy in the treatment of allergic rhinitis and asthma--a randomized prospective study from kashmir valley-north of India. | Roohi Rasool Wani (India)
3118
3118: The Effect of G2 Vaccine on the Gene Expression NKG2D and Receptor Presenting on the Surface of NK Cells in Peripheral Blood | Nader Dashti Gerdabi (Iran)
3119
3119: The Different Influence on the Regulatory T Cell Response Between Subcutanous Immnuotherapy(SCIT) and Sublingual Immunotherapy(SLIT) in Children with Asthma | Qing Miao (China)
3120
3120: Systemic side reaction of subcutaneous immunotherapy(SCIT) for perennial allergic rhinitis | Kun Hee Lee (South Korea)
3121
3121: A case report of successful intralymphatic immunotherapy in postorgasmic illness syndrome Jeong-Woong Park (South Korea)
3122
3122: Different Increases of Specific Immunoglobulin G4 By Different House Dust Mite Subcutaneous Immunotherapy Reagents | Kyung Hee Park (South Korea)
3123
3123: Pollen Exposure in a Mobile Exposure Chamber: Comparing Real-Life Symptoms with Exposure Symptoms | Karl-Christian Bergmann (Germany)
3125
3125: Localisation Kinetics of Aluminium after Subcutaneous Injection in a Rat Model | Alan David Bullimore (United Kingdom)
3126
3126: Efficacy and Safety of Sublingual Immunotherapy in House Dust Mite Sensitized Children with Allergic Rhinitis. | Yang Park (South Korea)
3127
3127: Preclinical Study on the Use of Micro Crystalline Tyrosine (MCT) Adjuvants in Allergy Immunotherapy | Alan David Bullimore (United Kingdom)
3128
3128: Systemic Cyclosporine Treatment in Hand Eczema Patients | Kyung Ho Kim (South Korea)
3129
3129: Protein and MPL Adsorption Capacities for MCT in Candidate Therapeutic Formulations for Use in Immunotherapy, Compared Against Existing Adjuvants | Alan David Bullimore (United Kingdom)
3130
3130: Pre-Coseasonal Treatment with a 5-Grass Pollen Sublingual Tablet in Adults Demonstrated a Reduction on Asthma Symptoms in Réunion Island. | Bashir Omarjee (Reunion)
3131
3131: Intralymphatic Immunotherapy for Dermatophagoides Farinae, Dermatophagoides Pteronyssinus, Cat, and/or Dog Allergy in Patients with Allergic Rhinitis: 1 Year Follow-up | Sang Min Lee (South Korea)
3132
3132: House Dust Mites Sublingual Immunotherapy Can Influence the Long-Term Evolution of Severe Atopic Dermatitis and the Progression to Respiratory Allergy. Enrico Compalati (Italy)
3133
3133: Risk Factors for Systemic and Local Reactions to Subcutaneous Allergen Immunotherapy | Hikmet Tekin Nacaroglu (Turkey)
3134
3134: Analysis of Allergen Immunotherapy Practice and Patients’ Knowledge and Attitude about Allergen Immunotherapy in a Single Tertiary Hospital in Korea | Young-Hee Nam (South Korea)
3135
3135: Skin Prick Test Result and Allergen Immunotherapy in Children with Allergic Rhinitis | Grace Shieh (Philippines)
3136
3136: Clinical Factors for Improved Allergen Reactivities Induced By Subcutaneous Allergen Specific Immunotherapy with House Dust Mites during 1 Year Period | Hee-Kyoo Kim (South Korea)
3137
3137: Sublingual Immunotherapy Among Problematic Patients, Suffering from Allergic Rhinitis. | Nataly Tataurshchikova (Russia)
3138
3138: The Efficiency of Immunotherapy to the Subjects with Allergy to Bee Venom and Its Influence in Pollen Allergy | Leonora Hana-Lleshi (Kosovo)
See more of: Poster Sessions
See more of: Abstract Presentations
<< Previous Session | Next Session >>